David Linetsky - Sep 12, 2023 Form 4 Insider Report for Phreesia, Inc. (PHR)

Signature
Alexis Lyons, as Attorney-in-Fact for David Linetsky
Stock symbol
PHR
Transactions as of
Sep 12, 2023
Transactions value $
$30,417
Form type
4
Date filed
9/14/2023, 05:04 PM
Previous filing
Jul 18, 2023
Next filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Award +3.28K +1.61% 207K Sep 12, 2023 Direct F1
transaction PHR Common Stock Options Exercise $2.24K +475 +0.23% $4.71* 208K Sep 12, 2023 Direct
transaction PHR Common Stock Options Exercise $45.7K +5.69K +2.74% $8.03 213K Sep 12, 2023 Direct
transaction PHR Common Stock Options Exercise $26.8K +5.69K +2.66% $4.71* 219K Sep 12, 2023 Direct
transaction PHR Common Stock Award +273 +3.5% 8.08K Sep 12, 2023 By spouse F2
transaction PHR Common Stock Sale -$40.1K -1.98K -0.9% $20.30 217K Sep 13, 2023 Direct F3, F4
transaction PHR Common Stock Sale -$1.74K -82 -0.04% $21.20 217K Sep 13, 2023 Direct F3, F5
transaction PHR Common Stock Sale -$2.31K -114 -1.41% $20.30 7.97K Sep 13, 2023 By spouse F3, F4
transaction PHR Common Stock Sale -$106 -5 -0.06% $21.20 7.96K Sep 13, 2023 By spouse F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Option Options Exercise $0 -5.69K -100% $0.00* 0 Sep 12, 2023 Common Stock 5.69K $8.03 Direct F6
transaction PHR Stock Option Options Exercise $0 -475 -100% $0.00* 0 Sep 12, 2023 Common Stock 475 $4.71 Direct F6
transaction PHR Stock Option Options Exercise $0 -5.69K -100% $0.00* 0 Sep 12, 2023 Common Stock 5.69K $4.71 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
F2 Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
F3 These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to $21.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.17 to $21.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 This option is fully vested and exercisable as of the date hereof.